Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Specifically...
22 KB (1,993 words) - 23:37, 23 March 2024
Quinazoline (section Erlotinib)
metastatic breast cancer. Erlotinib, an anti-tumor agent. Afatinib for treatment of cancers resistant to gefinitib and erlotinib. Quinazolinone Niementowski...
14 KB (1,240 words) - 15:17, 30 October 2023
Gimatecan Irinotecan Topotecan Etoposide Teniposide Tafluposide Bortezomib Erlotinib Gefitinib Imatinib Vemurafenib Vismodegib Azacitidine Azathioprine Capecitabine...
5 KB (313 words) - 21:41, 30 March 2024
its long-term safety. There are indications that the lung cancer drug erlotinib may be an additional treatment option for those with certain genetic markers...
24 KB (2,684 words) - 10:59, 5 June 2024
Erlotinib (marketed as Tarceva). Erlotinib inhibits epidermal growth factor receptor, and works through a similar mechanism as gefitinib. Erlotinib has...
20 KB (2,197 words) - 05:50, 29 November 2023
Nicolson M, Groves RW, et al. (2009). "Expert consensus on the management of erlotinib-associated cutaneous toxicity in the U.K." Oncologist. 14 (8): 840–7....
20 KB (1,962 words) - 03:47, 13 July 2024
mutations targeted by first generation tyrosine-kinase inhibitors (TKIs) like erlotinib or gefitinib, but also against less common mutations which are resistant...
14 KB (1,126 words) - 18:50, 30 November 2023
breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor...
21 KB (2,160 words) - 02:06, 24 May 2024
study of emibetuzumab plus erlotinib (LY+E) and emibetuzumab monotherapy (LY) in patients with acquired resistance to erlotinib and MET diagnostic positive...
2 KB (117 words) - 04:24, 3 April 2023
Mechanical Allergic Facial nerve palsy Anti-cancer treatments such as erlotinib, cetuximab, and panitumumab, which block the function of EGFR (the epidermal...
3 KB (220 words) - 15:43, 11 May 2024
inhibitors osimertinib, erlotinib, gefitinib, afatinib, or dacomitinib – with osimertinib known to be superior to erlotinib and gefitinib, and all superior...
90 KB (9,784 words) - 14:55, 21 June 2024
antagonists such as erlotinib (Tarceva) or gefitinib (Iressa). Patients who harbor an EGFR mutation have a 60% response rate to erlotinib. However, the mutation...
45 KB (5,079 words) - 06:39, 25 June 2024
However, the combination of gemcitabine with erlotinib was found to increase survival modestly, and erlotinib was licensed by the FDA for use in pancreatic...
122 KB (12,753 words) - 07:35, 20 May 2024
treatment with other EGFR tyrosine kinase inhibitors, such as gefitinib, erlotinib, and afatinib. In the US, EGFR exon 19 deletions, exon 21 L858R mutations...
17 KB (1,489 words) - 05:47, 7 April 2024
cancer. His research has included development of anti-cancer drugs such as erlotinib, nab-paclitaxel and temsirolimus, and the development of patient-derived...
2 KB (101 words) - 22:55, 5 July 2024
against EGFR (called "EGFR inhibitors", EGFRi), including gefitinib, erlotinib, afatinib, brigatinib and icotinib for lung cancer, and cetuximab for...
60 KB (6,879 words) - 09:57, 15 January 2024
molecular signature. In addition, the test appeared to be predictive of erlotinib impact on survival, as only "VeriStrat Good patients" benefited from such...
2 KB (282 words) - 18:47, 14 August 2023
(oseltamivir), for influenza A and B (both treatment and prevention). Tarceva (erlotinib), for various cancers. Tasmar (tolcapone), for parkinson's disease, licensed...
57 KB (5,236 words) - 09:00, 28 June 2024
Kinase inhibitors: Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin Icotinib Lapatinib Neratinib Osimertinib Vandetanib...
42 KB (3,935 words) - 04:01, 30 April 2024
developed against chronic myelogenous leukemia (CML) and later gefitinib and erlotinib aiming at the EGF receptor. Dasatinib is a Src tyrosine kinase inhibitor...
9 KB (1,081 words) - 04:46, 16 June 2022
chemotherapeutics: docetaxel, tamoxifen, paclitaxel, cyclophosphamide, doxorubicin, erlotinib, etoposide, ifosfamide, teniposide, vinblastine, vincristine, vindesine...
80 KB (7,810 words) - 23:14, 9 July 2024
Kinase inhibitors: Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin Icotinib Lapatinib Neratinib Osimertinib Vandetanib...
68 KB (5,993 words) - 00:47, 13 July 2024
Kinase inhibitors: Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin Icotinib Lapatinib Neratinib Osimertinib Vandetanib...
121 KB (13,799 words) - 06:42, 1 July 2024
Kinase inhibitors: Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin Icotinib Lapatinib Neratinib Osimertinib Vandetanib...
31 KB (3,413 words) - 23:30, 21 June 2024
pilot study suggested possible benefit from the tyrosine kinase inhibitor erlotinib in people with advanced cholangiocarcinoma. Radiation therapy appears...
74 KB (7,641 words) - 05:09, 17 June 2024
block the EGFR protein known as tyrosine kinase inhibitors specifically, erlotinib, gefitinib, afatinib, or osimertinib. Reliable identification of mutations...
50 KB (5,311 words) - 02:05, 10 July 2024
Kinase inhibitors: Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin Icotinib Lapatinib Neratinib Osimertinib Vandetanib...
150 KB (15,741 words) - 10:52, 27 June 2024
BRAF inhibitors sorafenib, vemurafenib -tinib Tyrosine-kinase inhibitors erlotinib, crizotinib -zomib proteasome inhibitors bortezomib, carfilzomib -vastatin...
26 KB (2,150 words) - 07:07, 12 June 2024
Kinase inhibitors: Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin Icotinib Lapatinib Neratinib Osimertinib Vandetanib...
92 KB (8,667 words) - 19:29, 28 June 2024
(eczema) Symoron (methadone HCL) – Opioid replacement therapy Tarceva (erlotinib) – Non-small cell lung cancer and pancreatic cancer – marketed with Hoffmann-La...
27 KB (2,449 words) - 21:35, 29 June 2024